Catalysts for GlaxoSmithKline LLC
412 tracked
Mar 27, 2026
approval
ZEJULA (NIRAPARIB TOSYLATE) — FDA approval
niraparib
→
Mar 23, 2026
approval
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Mar 20, 2026
approval
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Mar 18, 2026
approval
OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA approval
momelotinib dihydrochloride
→
Mar 18, 2026
approval
OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA approval
momelotinib dihydrochloride
→
Mar 17, 2026
approval
LYNAVOY (LINERIXIBAT) — FDA approval
linerixibat
→
Mar 9, 2026
approval
WELLCOVORIN (LEUCOVORIN CALCIUM) — FDA approval
LEUCOVORIN CALCIUM
→
Jan 21, 2026
recall
GOLD STAR DISTRIBUTION INC recall (Cls II)
GlaxoSmithKline LLC
→
Jan 21, 2026
recall
GOLD STAR DISTRIBUTION INC recall (Cls II)
GlaxoSmithKline LLC
→
Dec 19, 2025
approval
FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approval
GlaxoSmithKline LLC
→
Dec 16, 2025
approval
EXDENSUR (DEPEMOKIMAB-ULAA) — FDA approval
depemokimab
→
Dec 11, 2025
approval
BLUJEPA (GEPOTIDACIN MESYLATE) — FDA approval
gepotidacin mesylate
→
Dec 9, 2025
approval
IMITREX (SUMATRIPTAN SUCCINATE) — FDA approval
SUMATRIPTAN SUCCINATE
→
Dec 9, 2025
approval
IMITREX (SUMATRIPTAN) — FDA approval
SUMATRIPTAN SUCCINATE
→
Dec 9, 2025
approval
IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approval
SUMATRIPTAN SUCCINATE
→
Dec 1, 2025
approval
ALBUTEROL SULFATE — FDA approval
GlaxoSmithKline LLC
→
Nov 12, 2025
approval
VALTREX (VALACYCLOVIR HYDROCHLORIDE) — FDA approval
VALACYCLOVIR HYDROCHLORIDE
→
Nov 5, 2025
approval
WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
Nov 5, 2025
approval
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
Nov 3, 2025
approval
BREXAFEMME (IBREXAFUNGERP CITRATE) — FDA approval
ibrexafungerp citrate
→
Oct 23, 2025
approval
BLENREP (BELANTAMAB MAFODOTIN-BLMF) — FDA approval
belantamab mafodotin
→
Oct 10, 2025
approval
LAMICTAL XR (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Oct 10, 2025
approval
LAMICTAL XR (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Oct 10, 2025
approval
LAMICTAL CD (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Oct 10, 2025
approval
LAMICTAL CD (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Oct 10, 2025
approval
LAMICTAL (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Oct 10, 2025
approval
LAMICTAL (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Oct 10, 2025
approval
LAMICTAL ODT (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Oct 10, 2025
approval
LAMICTAL ODT (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Sep 15, 2025
approval
FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approval
GlaxoSmithKline LLC
→